Sotatercept Helps the Sickest Patients With Pulmonary Arterial Hypertension

(MedPage Today) — CHICAGO — Adding sotatercept (Winrevair) to the treatment regimen for pulmonary arterial hypertension (PAH) in high-risk patients helped delay serious outcomes in the ZENITH trial.
Among 172 patients, the drug reduced the…